Takuma Matoba

7PUBLICATIONS
15CO-AUTHORS
Molecular targetsInstruments and techniquesCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 19, 2025
Conversion Surgery After Administration of a TRK Inhibitor for Unresectable Parotid Gland Secretory Carcinoma.

Arisa Nagano, Takuma Matoba, Daisuke Kawakita

|Apr 01, 2025
Clinical Outcomes of Intensity Modulated Proton Therapy for Salivary Gland Carcinoma: High Local Control and Quality of Life Preservation.

Gaku Takano, Daisuke Kawakita, Hiromitsu Iwata

|Apr 30, 2024
Comprehensive genomic profiling of salivary gland carcinoma: Analysis of the Center for Cancer Genomics and Advanced Therapeutics database in Japan.

Sho Iwaki, Daisuke Kawakita, Toshitaka Nagao

|Jan 17, 2024
Impact of salvage chemotherapy after immune checkpoint inhibitor for recurrent or metastatic head and neck cancer.

Takuma Matoba, Kiyoshi Minohara, Daisuke Kawakita

|Aug 10, 2020
Proenkephalin+ regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function.

Hiroaki Shime, Mizuyu Odanaka, Makoto Tsuiji

|Aug 25, 2019
Third Epidemiological Analysis of Nasopharyngeal Carcinoma in the Central Region of Japan from 2006 to 2015.

Masafumi Kanno, Norihiko Narita, Yasushi Fujimoto

Pageof 2

Frequent Collaborators

4 joint publications

Sho Iwaki

2 joint publications

Hiroaki Shime

2 joint publications

Makoto Tsuiji

2 joint publications

Yoshiaki Yasumizu